InsidersTradesSigma
华恒生物: directors' dealings · France · AMF
SSE:688639FR·AMFMcap 8.1Bn€
Explore the full management transaction log of 华恒生物, a publicly traded company based in France. Shares trade on FR FR, under the supervision of AMF. Market capitalisation: €8.1bn. The latest transaction was disclosed on 6 June 2025 (Sale). Among the most active insiders: 唐思青. Every trade is free.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
26.47 €
Income statement
Revenue2.86 Bn€
Gross profit608.6 M€21% margin
Net income132.4 M€4.6% margin
Balance sheet & cash
Market cap8.15 Bn€
Total debt2.06 Bn€
Free Cash Flow−532.2 M€
Last declaration on 6 June 2025